Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Recurrent/Resistant High-Risk Neuroblastoma
NCT00053326Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2003
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenretinide in neuroblastoma, sponsored by National Cancer Institute. Started May 2003; status: completed.
02
Drugs
fenretinide
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00053326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053326.